These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
471 related articles for article (PubMed ID: 26813432)
1. [Phase II clinical trial of two different modes of administration of the induction chemotherapy for locally advanced nasopharyngeal carcinoma]. Bi T; Jin F; Wu W; Long J; Li Y; Gong X; Luo X; Li Z; He Q; Qu B Zhonghua Zhong Liu Za Zhi; 2015 Sep; 37(9):676-81. PubMed ID: 26813432 [TBL] [Abstract][Full Text] [Related]
2. [Induction chemotherapy with docetaxel plus cisplatin (TP regimen) followed by concurrent chemoradiotherapy with TP regimen versus cisplatin in treating locally advanced nasopharyngeal carcinoma]. Xie FY; Zou GR; Hu WH; Qi SN; Peng M; Li JS Ai Zheng; 2009 Mar; 28(3):279-85. PubMed ID: 19619443 [TBL] [Abstract][Full Text] [Related]
3. Effects of induction docetaxel, platinum, and fluorouracil chemotherapy in patients with stage III or IVA/B nasopharyngeal cancer treated with concurrent chemoradiation therapy: Final results of 2 parallel phase 2 clinical trials. Kong L; Zhang Y; Hu C; Guo Y; Lu JJ Cancer; 2017 Jun; 123(12):2258-2267. PubMed ID: 28192641 [TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant chemotherapy followed by concurrent chemoradiation for locally advanced nasopharyngeal carcinoma. Kong L; Zhang YW; Hu CS; Guo Y Chin J Cancer; 2010 May; 29(5):551-5. PubMed ID: 20426907 [TBL] [Abstract][Full Text] [Related]
5. Randomized study of sinusoidal chronomodulated versus flat intermittent induction chemotherapy with cisplatin and 5-fluorouracil followed by traditional radiotherapy for locoregionally advanced nasopharyngeal carcinoma. Lin HX; Hua YJ; Chen QY; Luo DH; Sun R; Qiu F; Mo HY; Mai HQ; Guo X; Xian LJ; Hong MH; Guo L Chin J Cancer; 2013 Sep; 32(9):502-11. PubMed ID: 23816561 [TBL] [Abstract][Full Text] [Related]
6. [Analysis of follow-up results of chrono-chemotherapy or conventional chemotherapy combined with intensity modulated radiotherapy in locally advanced nasopharyngeal carcinoma]. Liu KQ; Jin F; Jiang H; Wu WL; Li YY; Long JH; Luo XL; Gong XY; Chen XX; Liu LN; Gan JY; Zhou JJ Zhonghua Zhong Liu Za Zhi; 2020 Feb; 42(2):133-138. PubMed ID: 32135648 [No Abstract] [Full Text] [Related]
7. [Preliminary result of multi-center clinical trial on the docetaxel, 5-Fu and DDP in the treatment of advanced, recurrent or metastatic nasopharyngeal carcinoma]. Huang HQ; Cai QQ; Lin XB; Wang AL; Bu Q; Hu XH; Pan ZH; Li YH; Shuang YR; Guan ZZ Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):314-6. PubMed ID: 18788641 [TBL] [Abstract][Full Text] [Related]
8. Phase II study of docetaxel, cisplatin, and 5-FU induction chemotherapy followed by chemoradiotherapy in locoregionally advanced nasopharyngeal cancer. Bae WK; Hwang JE; Shim HJ; Cho SH; Lee JK; Lim SC; Chung WK; Chung IJ Cancer Chemother Pharmacol; 2010 Feb; 65(3):589-95. PubMed ID: 19830427 [TBL] [Abstract][Full Text] [Related]
9. A randomized phase II trial of induction chemotherapy followed by cisplatin chronotherapy versus constant rate delivery combined with radiotherapy. Zhang PX; Jin F; Li ZL; Wu WL; Li YY; Long JH; Chen GY; Chen XX; Gan JY; Gong XY; He QY; Bi T Chronobiol Int; 2018 Feb; 35(2):240-248. PubMed ID: 29215933 [TBL] [Abstract][Full Text] [Related]
10. [Evaluation of induction chemotherapy with vinorelbine plus cisplatin (NP) or docetaxel plus cisplatin (TP) combined with concurrent chemoradiotherapy for patients with locally advanced nasopharyngeal carcinoma]. Han SH; Yu L; Zhang Z; Zhang PJ; Song HP; Guo CY Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):623-6. PubMed ID: 24314223 [TBL] [Abstract][Full Text] [Related]
11. Phase I study of TPF neoadjuvant chemotherapy followed by radical radiotherapy in advanced nasopharyngeal carcinoma. Guo L; Lin HX; Xu M; Chen QY; Wang CT; Huang PY Chin J Cancer; 2010 Feb; 29(2):136-9. PubMed ID: 20109339 [TBL] [Abstract][Full Text] [Related]
12. [Comparison of efficacy of docetaxel combined cisplatin (TP regimen) and cisplatin combined 5-fluorouracil (PF regimen) on locally advanced nasopharyngeal carcinoma]. Xie FY; Qi SN; Hu WH; Zou GR; Peng M; Li JS Ai Zheng; 2007 Aug; 26(8):880-4. PubMed ID: 17697552 [TBL] [Abstract][Full Text] [Related]
13. Induction chemotherapy with lobaplatin and fluorouracil versus cisplatin and fluorouracil followed by chemoradiotherapy in patients with stage III-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised, controlled, phase 3 trial. Lv X; Cao X; Xia WX; Liu KY; Qiang MY; Guo L; Qian CN; Cao KJ; Mo HY; Li XM; Li ZH; Han F; He YX; Liu YM; Wu SX; Bai YR; Ke LR; Qiu WZ; Liang H; Liu GY; Miao JJ; Li WZ; Lv SH; Chen X; Zhao C; Xiang YQ; Guo X Lancet Oncol; 2021 May; 22(5):716-726. PubMed ID: 33857411 [TBL] [Abstract][Full Text] [Related]
14. Comparison of induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil (TPF) followed by radiation vs concurrent chemoradiotherapy with TPF in patients with locally advanced squamous cell carcinoma of the head and neck. Katori H; Tsukuda M Clin Oncol (R Coll Radiol); 2005 May; 17(3):148-52. PubMed ID: 15900997 [TBL] [Abstract][Full Text] [Related]
15. Retrospective Analysis of Induction Chemotherapy plus Concurrent Chemoradiotherapy under Intensity-Modulated Radiotherapy Mode for Locally Advanced Nasopharyngeal Carcinoma. Liao K; Tao HY; Zhan ZJ; Qiu WZ; Zheng RH Oncol Res Treat; 2021; 44(11):602-612. PubMed ID: 34601467 [TBL] [Abstract][Full Text] [Related]
16. International randomized phase 2 study on the addition of docetaxel to the combination of cisplatin and 5-fluorouracil in the induction treatment for nasopharyngeal carcinoma in children and adolescents. Casanova M; Özyar E; Patte C; Orbach D; Ferrari A; Veyrat-Follet C; Errihani H; Pan J; Zhang L; Shen L; Grzegorzewski KJ; Varan A Cancer Chemother Pharmacol; 2016 Feb; 77(2):289-98. PubMed ID: 26666649 [TBL] [Abstract][Full Text] [Related]
17. Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial. Sun Y; Li WF; Chen NY; Zhang N; Hu GQ; Xie FY; Sun Y; Chen XZ; Li JG; Zhu XD; Hu CS; Xu XY; Chen YY; Hu WH; Guo L; Mo HY; Chen L; Mao YP; Sun R; Ai P; Liang SB; Long GX; Zheng BM; Feng XL; Gong XC; Li L; Shen CY; Xu JY; Guo Y; Chen YM; Zhang F; Lin L; Tang LL; Liu MZ; Ma J Lancet Oncol; 2016 Nov; 17(11):1509-1520. PubMed ID: 27686945 [TBL] [Abstract][Full Text] [Related]
18. Survival benefit of adding docetaxel, cisplatin, and 5-fluorouracil induction chemotherapy to concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma with nodal Stage N2-3. Kawahira M; Yokota T; Hamauchi S; Onozawa Y; Ogawa H; Onoe T; Kamijo T; Iida Y; Nishimura T; Onitsuka T; Yasui H Jpn J Clin Oncol; 2017 Aug; 47(8):705-712. PubMed ID: 28431119 [TBL] [Abstract][Full Text] [Related]
19. A Retrospective Study to Compare Five Induction Chemotherapy Regimens Prior to Radiotherapy in the Reduction of Regional Lymph Node Size in Patients with Nasopharyngeal Carcinoma. Chen J; Qi J; Yu B; Peng XH; Wang F; Tan JJ; Chen QQ; Peng XY; Zeng FF; Liu X Med Sci Monit; 2018 Apr; 24():2562-2568. PubMed ID: 29697098 [TBL] [Abstract][Full Text] [Related]
20. Comparison of concurrent chemoradiotherapy versus induction chemotherapy followed by radiation in patients with nasopharyngeal carcinoma. Komatsu M; Tsukuda M; Matsuda H; Horiuchi C; Taguch T; Takahashi M; Nishimura G; Mori M; Niho T; Ishitoya J; Sakuma Y; Hirama M; Shiono O Anticancer Res; 2012 Feb; 32(2):681-6. PubMed ID: 22287763 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]